ArticleHealth & justice2026
To better understand why people use new psychoactive substances in prison - outcomes of polish, qualitative study.
Article in Health & justice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNew Psychoactive Substances (NPS) have become increasingly prevalent in prison environments, serving both social and emotional functions. While research has extensively examined NPS use in the general population, little is known about the specific motivations driving their use among incarcerated individuals. Given the restrictive nature of prison life, substance use motivations may differ from those outside correctional facilities. This study aimed to identify the key motives behind NPS use among prisoners in Poland.
results6 Focus Group Discussions (FGD) with prisoners and 32 individual interviews with staff were conducted in polish prisons and detention centers. Two main categories of motivations were identified: adaptation to prison rules and emotional regulation. The first category included gaining recognition and status among inmates, avoiding legal consequences due to NPS' lower detectability in drug tests, and economic incentives, as NPS serve as a form of currency in prison. Emotional motivations included stress relief, boredom, coping with isolation, family-related distress, and the continuation of pre-incarceration substance use. According to current study prisoners primarily use NPS as a coping mechanism within the prison environment.
conclusionsUsing NPS in prisons allows to better adapt to the specific conditions of prison life and regulate the emotions associated with being in prison. The properties of NPS make them a strong alternative to traditional drugs in prison settings. The findings emphasize the need for prison-specific prevention and intervention strategies that address both the structural and emotional factors contributing to NPS use. Future research should focus on assessing the prevalence of NPS use in correctional settings and evaluating the effectiveness of existing preventive measures.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.